Latest Regulatory Approvals News

OzAurum Resources has secured environmental approval for Stage 1 of its Mulgabbie North Gold Project, clearing a major regulatory hurdle and accelerating its path to near-term production.

Tetratherix Limited has raised approximately $5 million to fast-track its Tutelix prostate spacer into pivotal clinical trials across Australia and the US, aiming to improve radiation therapy for prostate cancer patients.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

Magnetite Mines Limited (ASX:MGT) has been awarded Federal Major Project Status for its Razorback Iron Ore Project, unlocking government support as it advances multi-commodity exploration across South Australia. The company is progressing rare earth, copper, and gold programs while positioning Razorback for long-term green steel supply.

Telix Pharmaceuticals has announced that Part 1 of its ProstACT Phase 3 trial for TLX591-Tx met its primary safety and dosimetry objectives, with no new safety concerns. The study’s success supports ongoing global enrolment in Part 2 and regulatory engagement in the US.

Buxton Resources has secured all necessary permits and funding to launch its inaugural drilling campaign at the Madman copper-gold project in Western Australia, targeting a promising Havieron-style magnetic anomaly.

BPM Minerals has resumed exploration at its Forelands Gold Project in WA, launching a 7,500m drilling campaign at Beachcomber and advancing Bonnie & Clyde towards maiden drilling. The project shows strong potential for a Tropicana-style gold discovery.

Toubani Resources has given the green light to its Kobada Gold Project in Mali, marking a significant milestone with construction now underway and first gold production targeted for late 2027.

Star Minerals has obtained the crucial Native Vegetation Clearing Permit, completing all regulatory approvals to commence mining at the Tumblegum South Gold Project in Western Australia.

Rhythm Biosciences has achieved a significant regulatory milestone with NATA accreditation for its ColoSTAT® blood-based colorectal cancer test, enabling its commercial rollout in Australia and strengthening reimbursement prospects.

MyState Limited has confirmed a fully franked ordinary dividend of 12 cents per share for the half-year ending December 2025, alongside an updated dividend reinvestment plan price reflecting recent trading activity.

Dyno Nobel has signed a binding agreement to sell its Phosphate Hill fertiliser business to Mayfair Australia Corporation, marking a strategic pivot to focus solely on its explosives operations. The deal, expected to complete in Q3 FY26, includes deferred payments and regulatory conditions.